NCT Number: NCT02223091
KOKON Consultation on Complementary Medicine in Oncology - a Pilot Study
The aim of the study is to investigate the effect of a consultation training program for physicians on the quality of their consultations of breast cancer patients regarding complementary medicine. We assume that the training program might enhance the communication of relevant information, empathy of the physicians or satisfaction with the consultation.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
Brustzentrum am Vivantes Klinikum am Urban, Berlin, Germany
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
for physicians:
- age >18 years
- working in a breast center of comprehensive cancer center
- able to consult 10 patients within working hours
- training group: able to participate in on-site-training
- not primarily treating the patients that are consulted
- good language skills (for consultations)
- informed consent
Inclusion criteria
for patients:
- age > 18 years
- female
- diagnosis of breast-cancer
- patient in the participating center
- good language skills (for consultations)
- informed consent
Treatment and study plan
Consultation by an untrained physician
BehavioralPrimary outcomes
-
Effectiveness of the training program
Time frame: day 1-7
This is an exploratory study. The main aim is to evaluate the effectiveness of the training program which will be achieved using the different outcome measures defined here as secondary outcome measures.
Secondary outcomes
-
Knowledge about complementary medicine in oncology and consultations (physicians)
Time frame: day 1-7
Questions regarding different topics relating to complementary medicine in oncology and consultations of oncology patients
-
Evaluation of each consultation session (physicians)
Time frame: day 1-7
Evaluation of the consultation session by the physicians (e.g. time spent on the consultation, difficulties, empathy etc.)
-
Empathy: CARE (patient)
Time frame: day 1-7
Empathy is assessed via an adaption of the German version of the Consultation and Relational Empathy scale (CARE)
-
Empathy: REM (patient)
Time frame: day 1-7
Empathy is assessed via an adapted version of the Rating Scales for the Assessment of Empathic Communication in Medical Interviews (REM)
-
Satisfaction with the consultation session (patient)
Time frame: day 1-7
Satisfaction with the consultation session is assessed via questions developed by the study team.
-
Quality of information (patient)
Time frame: day 1-7
Quality of the information is assessed via questions developed by the study team
-
Qualitative analysis of focus groups (physicians)
Time frame: day 1-7
Focus groups will be conducted with each group of physicians (trained and untrained). They will be analyzed using qualitative methods.
-
Qualitative analysis of videotapings of consultation sessions
Time frame: day 1-7
In each group (consulations by trained and by untrained physicians) 8 consultation sessions will be videotaped and analyzed with qualitative methods.
Sponsors and collaborators
Lead sponsor
Charite University, Berlin, Germany
Other
Collaborators
- Deutsche Krebshilfe e.V., Bonn (Germany)
Registry information
Official study title
Prospective, Multi-center, Cluster-randomized, Pragmatic, Mixed-method Pilot Study Evaluating a Consultation Training Program for Physicians Within the Framework of KOKON (Competence Network Complementary Medicine in Oncology)
Acronym: KOKON-AS
Important dates
- Study start
- 2014
- Primary completion
- 2015
- Study completion
- 2015
- First posted
- Aug 22, 2014
- Registry last updated
- Aug 4, 2015
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Seroma Formation After Modified Radical Mastectomy With Flap Fixation Technique in Breast Cancer Patients
NCT06243796
Breast Diseases, Breast Neoplasms
Nakhon Phanom, Thailand
View Trial DetailsCyclophosphamide, Paclitaxel, and Trastuzumab in Treating Stage I-II HER2/Neu Positive Breast Cancer After Surgery
NCT02654119
Breast Diseases, Breast Neoplasms
Norfolk, Nebraska, United States
View Trial DetailsTumor-Derived FGF19
NCT06068257
Breast Cancer, Breast Diseases
Orlando, Florida, United States
View Trial DetailsAfrican Cancer Genome: GMD
NCT05754658
Breast Cancer, Breast Diseases
Philadelphia, Pennsylvania, United States
View Trial Details